Classsic

Mar

Breakthrough Single-Dose Oral Treatment for Visceral Leishmaniasis Approved, Heralding New Hope

GENEVA – The global health community is celebrating a landmark achievement today as the World Health Organization (WHO) announced the formal Prequalification of ‘Zolexifan’, the first-ever single-dose oral treatment for visceral leishmaniasis (VL), also known as kala-azar. This devastating neglected tropical disease (NTD) affects hundreds of thousands annually, and until…

Mar

Business

AI-Powered Logistics Platforms Begin to Reshape Humanitarian Aid Delivery in East Africa

A new wave of artificial intelligence (AI) is beginning to transform the efficiency of humanitarian medical supply chains, with several major NGOs concluding successful pilot programmes in East Africa. These platforms use predictive analytics to forecast disease outbreaks and logistical needs with unprecedented accuracy. By analysing climate data, population movement,…

Mar

Uncategorized

The Global Fund Announces New Strategy to Bolster Local Manufacturing and Supply Chain Resilience

In a major policy shift, the Global Fund to Fight AIDS, Tuberculosis and Malaria has announced a new strategic initiative aimed at strengthening regional manufacturing hubs and building supply chain resilience in Africa and Southeast Asia. The move is a direct response to the vulnerabilities exposed during the COVID-19 pandemic,…

Contact Info

Breakthrough Single-Dose Oral Treatment for Visceral Leishmaniasis Approved, Heralding New Hope

AI-Powered Logistics Platforms Begin to Reshape Humanitarian Aid Delivery in East Africa

The Global Fund Announces New Strategy to Bolster Local Manufacturing and Supply Chain Resilience

Newsletter

Search

Blog categories

Recent comments